FLUZONE QUADRIVALENT (Sanofi Pasteur Inc.)
Welcome to the PulseAid listing for the FLUZONE QUADRIVALENT drug offered from Sanofi Pasteur Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi Pasteur Inc. |
| NON-PROPRIETARY NAME: | INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUK |
| SUBSTANCE NAME: | INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUK |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-07-01 |
| END MARKETING DATE: | 2018-06-30 |
FLUZONE QUADRIVALENT VACCINE Details:
| Item Description | FLUZONE QUADRIVALENT from Sanofi Pasteur Inc. |
| LABELER NAME: | Sanofi Pasteur Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2017-07-01 |
| END MARKETING DATE: | 2018-06-30 |
| PRODUCT ID: | 49281-417_25e00f2b-d034-4059-ac64-82cb489857a5 |
| PRODUCT NDC: | 49281-417 |
| APPLICATION NUMBER: | BLA103914 |
Other INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUK Pharmaceutical Manufacturers / Labelers:
